Interestingly, AT inhibited the beneficial effect of a combined activation of PPAR-β/δ and PPAR-γ in control, but not in IPF fibroblasts (Fig. 7F, lane 5 versus lane 6). Here, PPARG is linked to idiopathic pulmonary fibrosis.